{"gene":"RHO","run_date":"2026-06-14T21:17:39+00:00","timeline":{"discoveries":[{"year":1991,"finding":"Rhodopsin kinase binds to the cytoplasmic loops of photoactivated rhodopsin (Rho*) — specifically the V-VI loop is crucial for kinase binding (analogous to transducin binding) — and this binding stimulates the kinase's catalytic activity. Phosphorylation by rhodopsin kinase occurs exclusively at C-terminal serine/threonine sites of Rho*.","method":"Enzymatic truncation of rhodopsin C-terminus and cytoplasmic loops followed by rhodopsin kinase activity assays with exogenous peptide substrates; mastoparan peptide mimicry experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with multiple defined truncation mutants and orthogonal peptide assays in a single rigorous study","pmids":["2071581"],"is_preprint":false},{"year":1991,"finding":"The C-terminal region of the alpha subunit of transducin (Gt) interacts with photoactivated rhodopsin (Metarhodopsin II) and stabilizes the active conformation of the receptor; synthetic peptides from the alpha-t C-terminus mimic Gt in this interaction. The conformation of such a peptide bound to Metarhodopsin II was determined by 2D NMR, and mutant peptide analogs confirmed the structural model.","method":"Synthetic peptide binding assays, 2D NMR of peptide bound to Metarhodopsin II, peptide analog mutagenesis","journal":"Cellular and molecular neurobiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural determination plus mutagenesis validation in a single study, single lab","pmids":["1782650"],"is_preprint":false},{"year":1995,"finding":"Rhodopsin kinase phosphorylates photoactivated rhodopsin sequentially at C-terminal sites, with the first phosphate preferentially transferred to Ser-338, then Ser-343 and Thr-336. Arrestin binding to phosphorylated rhodopsin limits physiologically significant phosphorylation to no more than three sites; reduction of all-trans-retinal to all-trans-retinol also limits phosphorylation.","method":"Mass spectrometry sequencing of phosphopeptides, biochemical phosphorylation assays with rhodopsin kinase","journal":"Biophysical chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-specific MS identification of phosphorylation sites replicated across studies","pmids":["7662865"],"is_preprint":false},{"year":1996,"finding":"Ca2+-bound recoverin forms a complex with rhodopsin kinase preferentially at the membrane surface, and this membrane-associated ternary complex (Ca2+-recoverin–rhodopsin kinase–membrane) leads to effective suppression of rhodopsin kinase activity, inhibiting light-dependent phosphorylation of rhodopsin.","method":"Biochemical membrane association assays, rhodopsin kinase activity measurements with varying membrane concentrations and recoverin","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding and activity assays in vitro with dose-response, single lab","pmids":["8617359"],"is_preprint":false},{"year":1998,"finding":"Removal of rhodopsin's carboxy-terminal phosphorylation sites in transgenic mouse rods prolongs the flash response 20-fold and makes it highly variable; deletion of arrestin results in partial recovery with 100-fold slowed final recovery. These experiments establish that rhodopsin phosphorylation initiates deactivation and arrestin binding completes deactivation.","method":"Transgenic mouse models (C-terminal truncation, arrestin knockout), single-cell suction electrode electrophysiology of rod photoreceptors","journal":"Eye (London, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO/transgenic with defined electrophysiological phenotype, two complementary transgenic lines","pmids":["9775212"],"is_preprint":false},{"year":1998,"finding":"Electron cryo-microscopy and electron crystallography of 2D rhodopsin crystals revealed a 7.5 Å resolution 3D map showing seven transmembrane helices with distinct arrangement from bacteriorhodopsin: three helix layers near the intracellular (G protein-interacting) side, a retinal-binding cavity open toward the extracellular side, closed intracellularly by the long tilted helix 3, and closed extracellularly by the loop 4-5 linked by a disulfide bridge to the extracellular end of helix 3.","method":"Electron cryo-microscopy, image processing, and electron crystallography of 2D crystals","journal":"Eye (London, England)","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct structural determination by electron crystallography, foundational structural study","pmids":["9775210"],"is_preprint":false},{"year":2001,"finding":"Picosecond time-resolved spectroscopy of 11-cis locked rhodopsin analogs established that cis-trans isomerization of the 11-cis retinal chromophore is the primary photochemical reaction in rhodopsin. Femtosecond pump-probe spectroscopy showed formation of photorhodopsin within 200 fs and that the photoisomerization proceeds via a vibrationally coherent process. The protein environment facilitates efficient isomerization relative to retinal in solution.","method":"Picosecond time-resolved spectroscopy, femtosecond transient absorption (pump-probe), femtosecond fluorescence spectroscopy, locked retinal analogs","journal":"Biochemistry. Biokhimiia","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple ultrafast spectroscopic methods with retinal analog controls, independently replicated across labs","pmids":["11743865"],"is_preprint":false},{"year":2001,"finding":"X-ray crystal structure of bovine rhodopsin revealed the 3D arrangement of the 7-transmembrane helical bundle as a GPCR, showing the 11-cis-retinal chromophore covalently bound via Schiff base in a binding pocket, and demonstrated that rhodopsin's helix arrangement differs from bacteriorhodopsin despite both having heptahelical bundles.","method":"X-ray crystallography","journal":"Current opinion in structural biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure, landmark study replicated and extended by multiple subsequent structures","pmids":["11495733"],"is_preprint":false},{"year":2015,"finding":"When reconstituted into large unilamellar vesicles, rhodopsin functions as an ATP-independent phospholipid scramblase, accelerating transbilayer translocation of common phospholipids by more than 1000-fold to rates exceeding 10,000 phospholipids per rhodopsin per second.","method":"Reconstitution of rhodopsin into large unilamellar vesicles, phospholipid scramblase activity assay","journal":"Photochemical & photobiological sciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro reconstitution assay demonstrating enzymatic scramblase activity, single lab with quantitative measurements","pmids":["26179029"],"is_preprint":false},{"year":2015,"finding":"EPR spectroscopy with spin labeling identified light-induced transmembrane helical movements in rhodopsin upon photoactivation, characterizing functional loop dynamics, millisecond-timescale conformational changes, effects of partial agonists on opsin, and lipid interactions, establishing the structural basis of GPCR activation.","method":"Site-directed spin labeling, EPR spectroscopy, pulsed EPR (DEER/PELDOR)","journal":"Photochemical & photobiological sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct biophysical structural measurements in membrane environment, multiple EPR methods, single lab perspective review summarizing prior work","pmids":["26140679"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of pharmacologically stabilized opsin at 2.4 Å resolution revealed an open channel connecting the orthosteric retinal binding site with the membrane and the intradiscal lumen, sufficient in size to permit exchange of hydrophobic ligands such as retinal. Small molecule pharmacological chaperones bind at the orthosteric binding site and stabilize the receptor.","method":"X-ray crystallography (2.4 Å resolution), virtual and thermofluor screening for stabilizing ligands, chemical modification of stabilizing compounds","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution crystal structure with ligand-binding site validation and chemical modification series, single study","pmids":["29555765"],"is_preprint":false},{"year":2022,"finding":"Visual arrestin (ARR1) binding to light-activated phosphorylated rhodopsin facilitates rhodopsin dephosphorylation in vivo. In Arr1 knockout mouse rods, rhodopsin remained phosphorylated even after 3 hours in darkness, compared to near-complete dephosphorylation within 1 hour in wild-type. This effect required ARR1 binding competence (ARR1-3A mutant with binding rescued dephosphorylation), and was independent of transducin signaling or protein phosphatase 2A downregulation.","method":"Arrestin knockout mice, isoelectric focusing to resolve phosphorylated rhodopsin species, transducin double-knockout controls, ARR1-3A binding-competent mutant rescue","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean in vivo KO with defined molecular phenotype, multiple genetic controls, and rescue with binding-competent mutant","pmids":["35332081"],"is_preprint":false},{"year":2023,"finding":"Ubiquitylation of lysine residues on P23H misfolded rhodopsin drives its accelerated protein turnover/degradation. Mutation of all 11 lysine residues to arginine (K-null P23H) significantly reduced ubiquitylation and slowed protein turnover compared to intact P23H rhodopsin. Wild-type rhodopsin with all lysines mutated to arginine also showed significantly reduced ubiquitylation.","method":"Transfection of HEK293 cells with K-null P23H rhodopsin constructs, ubiquitylation assays, cycloheximide chase analysis of protein turnover","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined cell-based KO of modification sites with two orthogonal readouts (ubiquitylation and turnover), but single lab, cell line system","pmids":["37440077"],"is_preprint":false},{"year":2025,"finding":"The K296E rhodopsin mutant (constitutively active) mislocalizes and forms protein aggregates in photoreceptor cells in knockin mice, contributing to retinal degeneration. Aggregation propensity of K296E rhodopsin was confirmed in vitro and was dependent on species background: mouse and human rhodopsin backgrounds showed aggregation, while bovine background did not, indicating species-specific differences in aggregation.","method":"Knockin mouse generation, PROTEOSTAT dye staining for protein aggregates, in vitro aggregation assays across species backgrounds","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockin mouse model combined with in vitro aggregation assays and species-background controls, single lab","pmids":["40667763"],"is_preprint":false}],"current_model":"Rhodopsin is a heptahelical GPCR in rod photoreceptor cells that covalently binds 11-cis-retinal via a protonated Schiff base to Lys296; photon absorption triggers ultrafast (<200 fs) vibrationally coherent cis-trans isomerization of the chromophore, driving conformational changes through transmembrane helix rearrangements to form the catalytically active Metarhodopsin II state, which activates transducin (Gt) via interaction at cytoplasmic loops including the V-VI loop; deactivation proceeds by sequential rhodopsin kinase phosphorylation of C-terminal serines/threonines (Ser-338 first, then Ser-343 and Thr-336), which is inhibited by Ca2+-bound recoverin complexed with rhodopsin kinase at the membrane, followed by arrestin (ARR1) binding that both quenches G-protein signaling and—unexpectedly—facilitates subsequent rhodopsin dephosphorylation in vivo; misfolded rhodopsin mutants are ubiquitylated on lysine residues and degraded, and constitutively active mutants (e.g., K296E) can aggregate and mislocalize to cause retinal degeneration; rhodopsin additionally functions as an ATP-independent phospholipid scramblase when reconstituted in membranes."},"narrative":{"mechanistic_narrative":"Rhodopsin is the heptahelical G-protein-coupled receptor of rod photoreceptors that converts photon absorption into visual signaling [PMID:11495733]. Its seven-transmembrane bundle covalently binds 11-cis-retinal via a Schiff base within an extracellularly-open binding cavity closed intracellularly by the tilted helix 3 and stabilized by a disulfide bridge [PMID:9775210, PMID:11495733]; photon capture drives ultrafast (sub-200 fs), vibrationally coherent cis-trans isomerization of the chromophore, the primary photochemical event facilitated by the protein environment [PMID:11743865]. Isomerization propagates through light-induced transmembrane helical rearrangements [PMID:26140679] to form the active state, which is recognized by the C-terminal region of the transducin alpha subunit; this interaction stabilizes the active receptor conformation [PMID:1782650]. Signaling is terminated in two steps: rhodopsin kinase binds the cytoplasmic loops of photoactivated rhodopsin (notably the V-VI loop) and phosphorylates C-terminal serines/threonines sequentially, Ser-338 first then Ser-343 and Thr-336 [PMID:2071581, PMID:7662865], with phosphorylation initiating deactivation and arrestin binding completing it [PMID:9775212]; arrestin binding additionally facilitates subsequent in vivo dephosphorylation of rhodopsin [PMID:35332081]. Kinase activity is held in check by Ca2+-bound recoverin, which forms a membrane-associated complex with rhodopsin kinase to suppress phosphorylation [PMID:8617359]. Beyond signaling, reconstituted rhodopsin acts as an ATP-independent phospholipid scramblase, accelerating transbilayer phospholipid translocation over 1000-fold [PMID:26179029]. Misfolded and constitutively active mutants link rhodopsin to retinal degeneration: lysine ubiquitylation drives turnover of P23H misfolded rhodopsin [PMID:37440077], and the constitutively active K296E mutant aggregates and mislocalizes in photoreceptors in a species-dependent manner [PMID:40667763].","teleology":[{"year":1991,"claim":"Established how the deactivation machinery and the G protein engage the activated receptor, defining the cytoplasmic surface as the recognition hub for both rhodopsin kinase and transducin.","evidence":"C-terminal/cytoplasmic-loop truncation plus kinase activity assays, and synthetic transducin alpha C-terminal peptide binding with 2D NMR on Metarhodopsin II","pmids":["2071581","1782650"],"confidence":"High","gaps":["Full-length kinase-receptor and Gt-receptor complex structures not resolved here","Stoichiometry and kinetics of competing kinase vs Gt binding unresolved"]},{"year":1995,"claim":"Resolved the order and limit of C-terminal phosphorylation, showing deactivation is encoded by site-specific, sequential phosphate addition capped by arrestin.","evidence":"Mass spectrometry of phosphopeptides and biochemical phosphorylation assays","pmids":["7662865"],"confidence":"High","gaps":["Functional consequence of each individual site for downstream signaling not quantified here","In vivo phosphorylation kinetics not addressed"]},{"year":1996,"claim":"Identified the Ca2+/recoverin brake on deactivation, linking intracellular calcium to suppression of rhodopsin kinase activity.","evidence":"Membrane association and kinase activity assays with recoverin titration in vitro","pmids":["8617359"],"confidence":"Medium","gaps":["Structural basis of the ternary membrane complex not defined","In vivo contribution to light adaptation not tested in this study"]},{"year":1998,"claim":"Genetically separated the two deactivation steps in living rods, proving phosphorylation initiates and arrestin completes shutoff of the light response.","evidence":"Transgenic C-terminal truncation and arrestin-knockout mouse rods with single-cell suction electrode electrophysiology","pmids":["9775212"],"confidence":"High","gaps":["Molecular timing of arrestin recruitment relative to phosphorylation not resolved","Does not address dephosphorylation/recovery for the next cycle"]},{"year":1998,"claim":"Provided the first 3D architecture of rhodopsin, establishing the heptahelical fold distinct from bacteriorhodopsin and the retinal cavity geometry.","evidence":"Electron cryo-microscopy and electron crystallography of 2D crystals at 7.5 Å","pmids":["9775210"],"confidence":"High","gaps":["Resolution insufficient for side-chain detail","Active-state conformation not captured"]},{"year":2001,"claim":"Defined the primary photochemistry and the high-resolution ground-state structure, anchoring how chromophore isomerization initiates activation in a GPCR scaffold.","evidence":"Femtosecond/picosecond time-resolved spectroscopy with locked retinal analogs, and X-ray crystallography of bovine rhodopsin","pmids":["11743865","11495733"],"confidence":"High","gaps":["Coupling of femtosecond isomerization to slower helix movements not directly bridged","Active Metarhodopsin II structure not solved here"]},{"year":2015,"claim":"Demonstrated a non-canonical enzymatic function of rhodopsin as an ATP-independent phospholipid scramblase, and mapped light-induced helix dynamics underlying activation.","evidence":"Reconstitution into unilamellar vesicles with scramblase assay; site-directed spin labeling and EPR/DEER","pmids":["26179029","26140679"],"confidence":"High","gaps":["Physiological role of scramblase activity in rod membranes not established","Structural pathway of lipid translocation not identified"]},{"year":2018,"claim":"Revealed an open channel from the retinal pocket to the lipid bilayer and lumen, rationalizing ligand exchange and pharmacological chaperone stabilization of opsin.","evidence":"X-ray crystallography of stabilized opsin at 2.4 Å with thermofluor/virtual screening of stabilizing ligands","pmids":["29555765"],"confidence":"High","gaps":["Whether the channel is the physiological retinal entry/exit route in vivo not proven","Therapeutic efficacy of chaperones in disease models not addressed here"]},{"year":2022,"claim":"Uncovered an unexpected role for arrestin in promoting rhodopsin dephosphorylation in vivo, extending arrestin's function beyond signal quenching.","evidence":"Arrestin-knockout mice with isoelectric focusing, transducin double-knockout controls, and ARR1-3A binding-competent rescue","pmids":["35332081"],"confidence":"High","gaps":["Identity and recruitment of the responsible phosphatase not defined","Mechanism by which arrestin presents phosphosites for dephosphorylation unknown"]},{"year":2023,"claim":"Showed that lysine ubiquitylation targets misfolded rhodopsin for degradation, defining a quality-control route for disease-associated rhodopsin.","evidence":"HEK293 expression of K-null P23H constructs with ubiquitylation assays and cycloheximide chase","pmids":["37440077"],"confidence":"Medium","gaps":["E3 ligase and degradation pathway not identified","Cell-line system; relevance to photoreceptor degeneration not tested in vivo"]},{"year":2025,"claim":"Linked the constitutively active K296E mutant to aggregation and mislocalization in photoreceptors, with species-dependent aggregation propensity contributing to retinal degeneration.","evidence":"Knockin mouse models with PROTEOSTAT aggregate staining and in vitro aggregation assays across species backgrounds","pmids":["40667763"],"confidence":"Medium","gaps":["Molecular determinants of species-specific aggregation not pinpointed","Whether aggregation or constitutive signaling is the primary degenerative driver unresolved"]},{"year":null,"claim":"How the ultrafast chromophore isomerization is mechanistically coupled to the millisecond helix rearrangements that build the transducin-competent active state, and how quality-control degradation versus aggregation outcomes are decided for mutant rhodopsin, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of the rhodopsin-transducin-kinase signaling/deactivation supercomplex in the timeline","Phosphatase mediating arrestin-facilitated dephosphorylation unidentified","Physiological function of scramblase activity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,7]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[6,7]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[8]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[4,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[12,13]}],"complexes":[],"partners":["GRK1","GNAT1","SAG","RCVRN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P08100","full_name":"Rhodopsin","aliases":["Opsin-2"],"length_aa":348,"mass_kda":38.9,"function":"Photoreceptor required for image-forming vision at low light intensity (PubMed:7846071, PubMed:8107847). Required for photoreceptor cell viability after birth (PubMed:12566452, PubMed:2215617). Light-induced isomerization of the chromophore 11-cis-retinal to all-trans-retinal triggers a conformational change that activates signaling via G-proteins (PubMed:26200343, PubMed:28524165, PubMed:28753425, PubMed:8107847). Subsequent receptor phosphorylation mediates displacement of the bound G-protein alpha subunit by the arrestin SAG and terminates signaling (PubMed:26200343, PubMed:28524165)","subcellular_location":"Membrane; Cell projection, cilium, photoreceptor outer segment","url":"https://www.uniprot.org/uniprotkb/P08100/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RHO","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RHO","total_profiled":1310},"omim":[{"mim_id":"621527","title":"TRANSMEMBRANE PROTEIN 145; TMEM145","url":"https://www.omim.org/entry/621527"},{"mim_id":"621466","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2KK; CMT2KK","url":"https://www.omim.org/entry/621466"},{"mim_id":"621436","title":"MICROCEPHALY, PROGRESSIVE, WITH SIMPLIFIED GYRAL PATTERN AND CEREBELLAR HYPOPLASIA; MGCH","url":"https://www.omim.org/entry/621436"},{"mim_id":"621331","title":"BRAIN SMALL VESSEL DISEASE 5 WITH OSTEOPOROSIS; BSVD5","url":"https://www.omim.org/entry/621331"},{"mim_id":"621280","title":"RETINITIS PIGMENTOSA 100; RP100","url":"https://www.omim.org/entry/621280"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"retina","ntpm":3767.6}],"url":"https://www.proteinatlas.org/search/RHO"},"hgnc":{"alias_symbol":["OPN2","CSNBAD1"],"prev_symbol":["RP4"]},"alphafold":{"accession":"P08100","domains":[{"cath_id":"1.20.1070.10","chopping":"25-325","consensus_level":"high","plddt":91.9446,"start":25,"end":325}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P08100","model_url":"https://alphafold.ebi.ac.uk/files/AF-P08100-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P08100-F1-predicted_aligned_error_v6.png","plddt_mean":88.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RHO","jax_strain_url":"https://www.jax.org/strain/search?query=RHO"},"sequence":{"accession":"P08100","fasta_url":"https://rest.uniprot.org/uniprotkb/P08100.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P08100/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P08100"}},"corpus_meta":[{"pmid":"2071581","id":"PMC_2071581","title":"Mechanism of rhodopsin kinase activation.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2071581","citation_count":237,"is_preprint":false},{"pmid":"11743865","id":"PMC_11743865","title":"Photoisomerization in rhodopsin.","date":"2001","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/11743865","citation_count":132,"is_preprint":false},{"pmid":"24135424","id":"PMC_24135424","title":"Molecular complexes that direct rhodopsin transport to primary cilia.","date":"2013","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/24135424","citation_count":130,"is_preprint":false},{"pmid":"33979634","id":"PMC_33979634","title":"Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin.","date":"2021","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/33979634","citation_count":115,"is_preprint":false},{"pmid":"11495733","id":"PMC_11495733","title":"Crystal structure of rhodopsin: implications for vision and beyond.","date":"2001","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/11495733","citation_count":104,"is_preprint":false},{"pmid":"36273969","id":"PMC_36273969","title":"Rhodopsin, light-sensor of vision.","date":"2022","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/36273969","citation_count":83,"is_preprint":false},{"pmid":"26055054","id":"PMC_26055054","title":"Rhodopsin Trafficking and Mistrafficking: Signals, Molecular Components, and Mechanisms.","date":"2015","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/26055054","citation_count":66,"is_preprint":false},{"pmid":"33173168","id":"PMC_33173168","title":"NeoR, a near-infrared absorbing rhodopsin.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33173168","citation_count":64,"is_preprint":false},{"pmid":"22266727","id":"PMC_22266727","title":"Structure and activation of rhodopsin.","date":"2012","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/22266727","citation_count":62,"is_preprint":false},{"pmid":"9775210","id":"PMC_9775210","title":"Structure of rhodopsin.","date":"1998","source":"Eye (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9775210","citation_count":56,"is_preprint":false},{"pmid":"24931191","id":"PMC_24931191","title":"Constitutively active rhodopsin and retinal disease.","date":"2014","source":"Advances in pharmacology (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/24931191","citation_count":56,"is_preprint":false},{"pmid":"24041646","id":"PMC_24041646","title":"Relevance of rhodopsin studies for GPCR activation.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24041646","citation_count":51,"is_preprint":false},{"pmid":"12402507","id":"PMC_12402507","title":"Rhodopsin and retinitis pigmentosa: shedding light on structure and function.","date":"2002","source":"Receptors & channels","url":"https://pubmed.ncbi.nlm.nih.gov/12402507","citation_count":49,"is_preprint":false},{"pmid":"9775212","id":"PMC_9775212","title":"Control of rhodopsin activity in vision.","date":"1998","source":"Eye (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9775212","citation_count":41,"is_preprint":false},{"pmid":"20374723","id":"PMC_20374723","title":"Rhodopsin-mediated retinitis pigmentosa.","date":"2009","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/20374723","citation_count":39,"is_preprint":false},{"pmid":"26179029","id":"PMC_26179029","title":"Phospholipid scrambling by rhodopsin.","date":"2015","source":"Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26179029","citation_count":38,"is_preprint":false},{"pmid":"20423327","id":"PMC_20423327","title":"Complexes between photoactivated rhodopsin and transducin: progress and questions.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20423327","citation_count":38,"is_preprint":false},{"pmid":"26974343","id":"PMC_26974343","title":"Rhodopsin targeted transcriptional silencing by DNA-binding.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26974343","citation_count":35,"is_preprint":false},{"pmid":"29555765","id":"PMC_29555765","title":"Ligand channel in pharmacologically stabilized rhodopsin.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29555765","citation_count":32,"is_preprint":false},{"pmid":"18422873","id":"PMC_18422873","title":"Activity switches of rhodopsin.","date":"2008","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18422873","citation_count":29,"is_preprint":false},{"pmid":"8617359","id":"PMC_8617359","title":"Calcium-bound recoverin targets rhodopsin kinase to membranes to inhibit rhodopsin phosphorylation.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8617359","citation_count":26,"is_preprint":false},{"pmid":"1782650","id":"PMC_1782650","title":"Molecular interactions between the photoreceptor G protein and rhodopsin.","date":"1991","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/1782650","citation_count":26,"is_preprint":false},{"pmid":"32351353","id":"PMC_32351353","title":"Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases.","date":"2020","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32351353","citation_count":24,"is_preprint":false},{"pmid":"7662865","id":"PMC_7662865","title":"Mechanism of rhodopsin phosphorylation.","date":"1995","source":"Biophysical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7662865","citation_count":21,"is_preprint":false},{"pmid":"31286171","id":"PMC_31286171","title":"Rhodopsin Oligomerization and Aggregation.","date":"2019","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/31286171","citation_count":20,"is_preprint":false},{"pmid":"37120702","id":"PMC_37120702","title":"Rhodopsin-mediated nutrient uptake by cultivated photoheterotrophic Verrucomicrobiota.","date":"2023","source":"The ISME journal","url":"https://pubmed.ncbi.nlm.nih.gov/37120702","citation_count":17,"is_preprint":false},{"pmid":"37159291","id":"PMC_37159291","title":"Mechanism of Activation of the Visual Receptor Rhodopsin.","date":"2023","source":"Annual review of biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/37159291","citation_count":16,"is_preprint":false},{"pmid":"26140679","id":"PMC_26140679","title":"Characterizing rhodopsin signaling by EPR spectroscopy: from structure to dynamics.","date":"2015","source":"Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26140679","citation_count":11,"is_preprint":false},{"pmid":"12596917","id":"PMC_12596917","title":"Recoverin and rhodopsin kinase.","date":"2002","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/12596917","citation_count":10,"is_preprint":false},{"pmid":"33591421","id":"PMC_33591421","title":"Supramolecular organization of rhodopsin in rod photoreceptor cell membranes.","date":"2021","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33591421","citation_count":10,"is_preprint":false},{"pmid":"9303550","id":"PMC_9303550","title":"High levels of rhodopsin phosphorylation in missense mutations of C-terminal region of rhodopsin.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9303550","citation_count":9,"is_preprint":false},{"pmid":"10614053","id":"PMC_10614053","title":"Calcium-dependent regulation of rhodopsin phosphorylation.","date":"1999","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/10614053","citation_count":7,"is_preprint":false},{"pmid":"34962636","id":"PMC_34962636","title":"Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa.","date":"2022","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/34962636","citation_count":7,"is_preprint":false},{"pmid":"35857223","id":"PMC_35857223","title":"Rhodopsin-Based Optogenetics: Basics and Applications.","date":"2022","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/35857223","citation_count":6,"is_preprint":false},{"pmid":"39550612","id":"PMC_39550612","title":"Hidden water's influence on rhodopsin activation.","date":"2024","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/39550612","citation_count":6,"is_preprint":false},{"pmid":"35332081","id":"PMC_35332081","title":"Arrestin Facilitates Rhodopsin Dephosphorylation in Vivo.","date":"2022","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35332081","citation_count":5,"is_preprint":false},{"pmid":"35940643","id":"PMC_35940643","title":"Gene Therapy for Rhodopsin Mutations.","date":"2022","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35940643","citation_count":4,"is_preprint":false},{"pmid":"37440077","id":"PMC_37440077","title":"Lysine Ubiquitylation Drives Rhodopsin Protein Turnover.","date":"2023","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/37440077","citation_count":2,"is_preprint":false},{"pmid":"40667763","id":"PMC_40667763","title":"Aggregation of the Constitutively Active K296E Rhodopsin Mutant Contributes to Retinal Degeneration.","date":"2025","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40667763","citation_count":1,"is_preprint":false},{"pmid":"41540734","id":"PMC_41540734","title":"Rhodopsin: The hydrogen atom of membrane biophysics.","date":"2026","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/41540734","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"sonnet_model":"claude-sonnet-4-6","sonnet_input_tokens":16883,"sonnet_output_tokens":3657,"sonnet_usd":0.1055,"sonnet_elapsed_seconds":67.9,"stage1_stop_reason":"end_turn"},"stage2":{"opus_model":"claude-opus-4-8","opus_input_tokens":11462,"opus_output_tokens":3721,"opus_usd":0.1503,"opus_elapsed_seconds":44.0,"stage2_stop_reason":"end_turn"},"total_usd":0.2558},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"Rhodopsin kinase binds to the cytoplasmic loops of photoactivated rhodopsin (Rho*) — specifically the V-VI loop is crucial for kinase binding (analogous to transducin binding) — and this binding stimulates the kinase's catalytic activity. Phosphorylation by rhodopsin kinase occurs exclusively at C-terminal serine/threonine sites of Rho*.\",\n      \"method\": \"Enzymatic truncation of rhodopsin C-terminus and cytoplasmic loops followed by rhodopsin kinase activity assays with exogenous peptide substrates; mastoparan peptide mimicry experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with multiple defined truncation mutants and orthogonal peptide assays in a single rigorous study\",\n      \"pmids\": [\"2071581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The C-terminal region of the alpha subunit of transducin (Gt) interacts with photoactivated rhodopsin (Metarhodopsin II) and stabilizes the active conformation of the receptor; synthetic peptides from the alpha-t C-terminus mimic Gt in this interaction. The conformation of such a peptide bound to Metarhodopsin II was determined by 2D NMR, and mutant peptide analogs confirmed the structural model.\",\n      \"method\": \"Synthetic peptide binding assays, 2D NMR of peptide bound to Metarhodopsin II, peptide analog mutagenesis\",\n      \"journal\": \"Cellular and molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural determination plus mutagenesis validation in a single study, single lab\",\n      \"pmids\": [\"1782650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Rhodopsin kinase phosphorylates photoactivated rhodopsin sequentially at C-terminal sites, with the first phosphate preferentially transferred to Ser-338, then Ser-343 and Thr-336. Arrestin binding to phosphorylated rhodopsin limits physiologically significant phosphorylation to no more than three sites; reduction of all-trans-retinal to all-trans-retinol also limits phosphorylation.\",\n      \"method\": \"Mass spectrometry sequencing of phosphopeptides, biochemical phosphorylation assays with rhodopsin kinase\",\n      \"journal\": \"Biophysical chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-specific MS identification of phosphorylation sites replicated across studies\",\n      \"pmids\": [\"7662865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Ca2+-bound recoverin forms a complex with rhodopsin kinase preferentially at the membrane surface, and this membrane-associated ternary complex (Ca2+-recoverin–rhodopsin kinase–membrane) leads to effective suppression of rhodopsin kinase activity, inhibiting light-dependent phosphorylation of rhodopsin.\",\n      \"method\": \"Biochemical membrane association assays, rhodopsin kinase activity measurements with varying membrane concentrations and recoverin\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding and activity assays in vitro with dose-response, single lab\",\n      \"pmids\": [\"8617359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Removal of rhodopsin's carboxy-terminal phosphorylation sites in transgenic mouse rods prolongs the flash response 20-fold and makes it highly variable; deletion of arrestin results in partial recovery with 100-fold slowed final recovery. These experiments establish that rhodopsin phosphorylation initiates deactivation and arrestin binding completes deactivation.\",\n      \"method\": \"Transgenic mouse models (C-terminal truncation, arrestin knockout), single-cell suction electrode electrophysiology of rod photoreceptors\",\n      \"journal\": \"Eye (London, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO/transgenic with defined electrophysiological phenotype, two complementary transgenic lines\",\n      \"pmids\": [\"9775212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Electron cryo-microscopy and electron crystallography of 2D rhodopsin crystals revealed a 7.5 Å resolution 3D map showing seven transmembrane helices with distinct arrangement from bacteriorhodopsin: three helix layers near the intracellular (G protein-interacting) side, a retinal-binding cavity open toward the extracellular side, closed intracellularly by the long tilted helix 3, and closed extracellularly by the loop 4-5 linked by a disulfide bridge to the extracellular end of helix 3.\",\n      \"method\": \"Electron cryo-microscopy, image processing, and electron crystallography of 2D crystals\",\n      \"journal\": \"Eye (London, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct structural determination by electron crystallography, foundational structural study\",\n      \"pmids\": [\"9775210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Picosecond time-resolved spectroscopy of 11-cis locked rhodopsin analogs established that cis-trans isomerization of the 11-cis retinal chromophore is the primary photochemical reaction in rhodopsin. Femtosecond pump-probe spectroscopy showed formation of photorhodopsin within 200 fs and that the photoisomerization proceeds via a vibrationally coherent process. The protein environment facilitates efficient isomerization relative to retinal in solution.\",\n      \"method\": \"Picosecond time-resolved spectroscopy, femtosecond transient absorption (pump-probe), femtosecond fluorescence spectroscopy, locked retinal analogs\",\n      \"journal\": \"Biochemistry. Biokhimiia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple ultrafast spectroscopic methods with retinal analog controls, independently replicated across labs\",\n      \"pmids\": [\"11743865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"X-ray crystal structure of bovine rhodopsin revealed the 3D arrangement of the 7-transmembrane helical bundle as a GPCR, showing the 11-cis-retinal chromophore covalently bound via Schiff base in a binding pocket, and demonstrated that rhodopsin's helix arrangement differs from bacteriorhodopsin despite both having heptahelical bundles.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Current opinion in structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure, landmark study replicated and extended by multiple subsequent structures\",\n      \"pmids\": [\"11495733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"When reconstituted into large unilamellar vesicles, rhodopsin functions as an ATP-independent phospholipid scramblase, accelerating transbilayer translocation of common phospholipids by more than 1000-fold to rates exceeding 10,000 phospholipids per rhodopsin per second.\",\n      \"method\": \"Reconstitution of rhodopsin into large unilamellar vesicles, phospholipid scramblase activity assay\",\n      \"journal\": \"Photochemical & photobiological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro reconstitution assay demonstrating enzymatic scramblase activity, single lab with quantitative measurements\",\n      \"pmids\": [\"26179029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EPR spectroscopy with spin labeling identified light-induced transmembrane helical movements in rhodopsin upon photoactivation, characterizing functional loop dynamics, millisecond-timescale conformational changes, effects of partial agonists on opsin, and lipid interactions, establishing the structural basis of GPCR activation.\",\n      \"method\": \"Site-directed spin labeling, EPR spectroscopy, pulsed EPR (DEER/PELDOR)\",\n      \"journal\": \"Photochemical & photobiological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biophysical structural measurements in membrane environment, multiple EPR methods, single lab perspective review summarizing prior work\",\n      \"pmids\": [\"26140679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of pharmacologically stabilized opsin at 2.4 Å resolution revealed an open channel connecting the orthosteric retinal binding site with the membrane and the intradiscal lumen, sufficient in size to permit exchange of hydrophobic ligands such as retinal. Small molecule pharmacological chaperones bind at the orthosteric binding site and stabilize the receptor.\",\n      \"method\": \"X-ray crystallography (2.4 Å resolution), virtual and thermofluor screening for stabilizing ligands, chemical modification of stabilizing compounds\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution crystal structure with ligand-binding site validation and chemical modification series, single study\",\n      \"pmids\": [\"29555765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Visual arrestin (ARR1) binding to light-activated phosphorylated rhodopsin facilitates rhodopsin dephosphorylation in vivo. In Arr1 knockout mouse rods, rhodopsin remained phosphorylated even after 3 hours in darkness, compared to near-complete dephosphorylation within 1 hour in wild-type. This effect required ARR1 binding competence (ARR1-3A mutant with binding rescued dephosphorylation), and was independent of transducin signaling or protein phosphatase 2A downregulation.\",\n      \"method\": \"Arrestin knockout mice, isoelectric focusing to resolve phosphorylated rhodopsin species, transducin double-knockout controls, ARR1-3A binding-competent mutant rescue\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean in vivo KO with defined molecular phenotype, multiple genetic controls, and rescue with binding-competent mutant\",\n      \"pmids\": [\"35332081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Ubiquitylation of lysine residues on P23H misfolded rhodopsin drives its accelerated protein turnover/degradation. Mutation of all 11 lysine residues to arginine (K-null P23H) significantly reduced ubiquitylation and slowed protein turnover compared to intact P23H rhodopsin. Wild-type rhodopsin with all lysines mutated to arginine also showed significantly reduced ubiquitylation.\",\n      \"method\": \"Transfection of HEK293 cells with K-null P23H rhodopsin constructs, ubiquitylation assays, cycloheximide chase analysis of protein turnover\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined cell-based KO of modification sites with two orthogonal readouts (ubiquitylation and turnover), but single lab, cell line system\",\n      \"pmids\": [\"37440077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The K296E rhodopsin mutant (constitutively active) mislocalizes and forms protein aggregates in photoreceptor cells in knockin mice, contributing to retinal degeneration. Aggregation propensity of K296E rhodopsin was confirmed in vitro and was dependent on species background: mouse and human rhodopsin backgrounds showed aggregation, while bovine background did not, indicating species-specific differences in aggregation.\",\n      \"method\": \"Knockin mouse generation, PROTEOSTAT dye staining for protein aggregates, in vitro aggregation assays across species backgrounds\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockin mouse model combined with in vitro aggregation assays and species-background controls, single lab\",\n      \"pmids\": [\"40667763\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Rhodopsin is a heptahelical GPCR in rod photoreceptor cells that covalently binds 11-cis-retinal via a protonated Schiff base to Lys296; photon absorption triggers ultrafast (<200 fs) vibrationally coherent cis-trans isomerization of the chromophore, driving conformational changes through transmembrane helix rearrangements to form the catalytically active Metarhodopsin II state, which activates transducin (Gt) via interaction at cytoplasmic loops including the V-VI loop; deactivation proceeds by sequential rhodopsin kinase phosphorylation of C-terminal serines/threonines (Ser-338 first, then Ser-343 and Thr-336), which is inhibited by Ca2+-bound recoverin complexed with rhodopsin kinase at the membrane, followed by arrestin (ARR1) binding that both quenches G-protein signaling and—unexpectedly—facilitates subsequent rhodopsin dephosphorylation in vivo; misfolded rhodopsin mutants are ubiquitylated on lysine residues and degraded, and constitutively active mutants (e.g., K296E) can aggregate and mislocalize to cause retinal degeneration; rhodopsin additionally functions as an ATP-independent phospholipid scramblase when reconstituted in membranes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Rhodopsin is the heptahelical G-protein-coupled receptor of rod photoreceptors that converts photon absorption into visual signaling [#7]. Its seven-transmembrane bundle covalently binds 11-cis-retinal via a Schiff base within an extracellularly-open binding cavity closed intracellularly by the tilted helix 3 and stabilized by a disulfide bridge [#5, #7]; photon capture drives ultrafast (sub-200 fs), vibrationally coherent cis-trans isomerization of the chromophore, the primary photochemical event facilitated by the protein environment [#6]. Isomerization propagates through light-induced transmembrane helical rearrangements [#9] to form the active state, which is recognized by the C-terminal region of the transducin alpha subunit; this interaction stabilizes the active receptor conformation [#1]. Signaling is terminated in two steps: rhodopsin kinase binds the cytoplasmic loops of photoactivated rhodopsin (notably the V-VI loop) and phosphorylates C-terminal serines/threonines sequentially, Ser-338 first then Ser-343 and Thr-336 [#0, #2], with phosphorylation initiating deactivation and arrestin binding completing it [#4]; arrestin binding additionally facilitates subsequent in vivo dephosphorylation of rhodopsin [#11]. Kinase activity is held in check by Ca2+-bound recoverin, which forms a membrane-associated complex with rhodopsin kinase to suppress phosphorylation [#3]. Beyond signaling, reconstituted rhodopsin acts as an ATP-independent phospholipid scramblase, accelerating transbilayer phospholipid translocation over 1000-fold [#8]. Misfolded and constitutively active mutants link rhodopsin to retinal degeneration: lysine ubiquitylation drives turnover of P23H misfolded rhodopsin [#12], and the constitutively active K296E mutant aggregates and mislocalizes in photoreceptors in a species-dependent manner [#13].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established how the deactivation machinery and the G protein engage the activated receptor, defining the cytoplasmic surface as the recognition hub for both rhodopsin kinase and transducin.\",\n      \"evidence\": \"C-terminal/cytoplasmic-loop truncation plus kinase activity assays, and synthetic transducin alpha C-terminal peptide binding with 2D NMR on Metarhodopsin II\",\n      \"pmids\": [\"2071581\", \"1782650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length kinase-receptor and Gt-receptor complex structures not resolved here\", \"Stoichiometry and kinetics of competing kinase vs Gt binding unresolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Resolved the order and limit of C-terminal phosphorylation, showing deactivation is encoded by site-specific, sequential phosphate addition capped by arrestin.\",\n      \"evidence\": \"Mass spectrometry of phosphopeptides and biochemical phosphorylation assays\",\n      \"pmids\": [\"7662865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of each individual site for downstream signaling not quantified here\", \"In vivo phosphorylation kinetics not addressed\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified the Ca2+/recoverin brake on deactivation, linking intracellular calcium to suppression of rhodopsin kinase activity.\",\n      \"evidence\": \"Membrane association and kinase activity assays with recoverin titration in vitro\",\n      \"pmids\": [\"8617359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the ternary membrane complex not defined\", \"In vivo contribution to light adaptation not tested in this study\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Genetically separated the two deactivation steps in living rods, proving phosphorylation initiates and arrestin completes shutoff of the light response.\",\n      \"evidence\": \"Transgenic C-terminal truncation and arrestin-knockout mouse rods with single-cell suction electrode electrophysiology\",\n      \"pmids\": [\"9775212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular timing of arrestin recruitment relative to phosphorylation not resolved\", \"Does not address dephosphorylation/recovery for the next cycle\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Provided the first 3D architecture of rhodopsin, establishing the heptahelical fold distinct from bacteriorhodopsin and the retinal cavity geometry.\",\n      \"evidence\": \"Electron cryo-microscopy and electron crystallography of 2D crystals at 7.5 Å\",\n      \"pmids\": [\"9775210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Resolution insufficient for side-chain detail\", \"Active-state conformation not captured\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the primary photochemistry and the high-resolution ground-state structure, anchoring how chromophore isomerization initiates activation in a GPCR scaffold.\",\n      \"evidence\": \"Femtosecond/picosecond time-resolved spectroscopy with locked retinal analogs, and X-ray crystallography of bovine rhodopsin\",\n      \"pmids\": [\"11743865\", \"11495733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coupling of femtosecond isomerization to slower helix movements not directly bridged\", \"Active Metarhodopsin II structure not solved here\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated a non-canonical enzymatic function of rhodopsin as an ATP-independent phospholipid scramblase, and mapped light-induced helix dynamics underlying activation.\",\n      \"evidence\": \"Reconstitution into unilamellar vesicles with scramblase assay; site-directed spin labeling and EPR/DEER\",\n      \"pmids\": [\"26179029\", \"26140679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of scramblase activity in rod membranes not established\", \"Structural pathway of lipid translocation not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed an open channel from the retinal pocket to the lipid bilayer and lumen, rationalizing ligand exchange and pharmacological chaperone stabilization of opsin.\",\n      \"evidence\": \"X-ray crystallography of stabilized opsin at 2.4 Å with thermofluor/virtual screening of stabilizing ligands\",\n      \"pmids\": [\"29555765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the channel is the physiological retinal entry/exit route in vivo not proven\", \"Therapeutic efficacy of chaperones in disease models not addressed here\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Uncovered an unexpected role for arrestin in promoting rhodopsin dephosphorylation in vivo, extending arrestin's function beyond signal quenching.\",\n      \"evidence\": \"Arrestin-knockout mice with isoelectric focusing, transducin double-knockout controls, and ARR1-3A binding-competent rescue\",\n      \"pmids\": [\"35332081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity and recruitment of the responsible phosphatase not defined\", \"Mechanism by which arrestin presents phosphosites for dephosphorylation unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed that lysine ubiquitylation targets misfolded rhodopsin for degradation, defining a quality-control route for disease-associated rhodopsin.\",\n      \"evidence\": \"HEK293 expression of K-null P23H constructs with ubiquitylation assays and cycloheximide chase\",\n      \"pmids\": [\"37440077\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase and degradation pathway not identified\", \"Cell-line system; relevance to photoreceptor degeneration not tested in vivo\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linked the constitutively active K296E mutant to aggregation and mislocalization in photoreceptors, with species-dependent aggregation propensity contributing to retinal degeneration.\",\n      \"evidence\": \"Knockin mouse models with PROTEOSTAT aggregate staining and in vitro aggregation assays across species backgrounds\",\n      \"pmids\": [\"40667763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular determinants of species-specific aggregation not pinpointed\", \"Whether aggregation or constitutive signaling is the primary degenerative driver unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the ultrafast chromophore isomerization is mechanistically coupled to the millisecond helix rearrangements that build the transducin-competent active state, and how quality-control degradation versus aggregation outcomes are decided for mutant rhodopsin, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the rhodopsin-transducin-kinase signaling/deactivation supercomplex in the timeline\", \"Phosphatase mediating arrestin-facilitated dephosphorylation unidentified\", \"Physiological function of scramblase activity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [12, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GRK1\", \"GNAT1\", \"SAG\", \"RCVRN\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":{"gene":"RHO","tier":"IDENTITY","verdict":"Identity concern","subtype":"corpus_ungrounded","uniprot_band":"medium","rules_fired":"R1,R6","issue":"R1: gene named in 4/40 (10%) of its own corpus abstracts (< 25%) — corpus likely a paralog/alias collision; R6: narrative-cited PMIDs vs gene2pubmed overlap = 0.00% (n_cited=14, n_g2p=246)"},"evaluation":{"pairwise":"tie"}}